Newsletter | July 2, 2025

07.02.25 -- The Effects Of Most Favored Nation Drug Pricing On Clinical Trial Management

SPONSOR

As clinical trials grow increasingly complex, traditional monitoring models are showing their cracks. Overextended CRAs, inconsistent site engagement, and reactive oversight can lead to delays, data quality issues, and strained site relationships. Join clinical operations experts for a candid conversation about what's not working in today's trial monitoring—and what could.

DECENTRALIZED TRIALS

In Clinical Research, Every Day Is Groundhog Day

Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.

The Final DCT Guidance: I'm Not Mad At It

Article | By Catherine Gregor, Florence Healthcare

Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.


Pioneering The End-To-End Decentralized Trial Experience

Case Study | Medidata, a Dassault Systemes company

This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.


Leveraging Mobile Research Nurses For Vulnerable Patient Populations

Video | PCM Trials

Dr. Steven Cummings highlights the role of PCM Trials certified mobile research nurses in making possible large-scale home-based clinical trial.


TRIAL MANAGEMENT

The Effects Of Most Favored Nation Drug Pricing On Clinical Trial Management

Guest Column | By Mathini Ilancheran, Beroe Inc.

Market expert Mathini Ilancheran explains how sponsors can mitigate the effects of "Most Favored Nation" drug pricing while maintaining trial integrity and accelerating time to market.

Decoding The Human Immune System

Podcast | Biorasi

Michael Tolentino MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics, discusses the power of glycol therapeutics in treating degenerative eye diseases. 


Why EHR Data Is The Game Changer For Life Sciences Success

White Paper | Verana Health

The pharmaceutical industry faces soaring costs and shrinking ROI. Discover why leveraging rich real-world data is now essential for driving efficiency, innovation, and competitive advantage.


Checklist For Risk Management In Document Reviews

Infographic | Ideagen

Learn how medical writers support effective product development by managing collaboration risks and maintaining quality using tools like document review systems in regulatory submissions.


High-Content Flow Cytometry

Brochure | Precision for Medicine

Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.


SURVEY

Have you outsourced in clinical trials?

Tell Clinical Leader how we can better support you in finding the right partners. 

 

Share your thoughts here.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: